Compare MIRM & SHAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIRM | SHAK |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.6B |
| IPO Year | 2019 | 2015 |
| Metric | MIRM | SHAK |
|---|---|---|
| Price | $91.35 | $96.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 21 |
| Target Price | $97.55 | ★ $115.05 |
| AVG Volume (30 Days) | 836.6K | ★ 1.6M |
| Earning Date | 02-25-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 425.42 |
| EPS | N/A | ★ 1.02 |
| Revenue | $471,794,000.00 | ★ $1,373,459,000.00 |
| Revenue This Year | $54.25 | $18.23 |
| Revenue Next Year | $21.09 | $13.50 |
| P/E Ratio | ★ N/A | $95.09 |
| Revenue Growth | ★ 53.66 | 13.49 |
| 52 Week Low | $36.88 | $72.93 |
| 52 Week High | $93.70 | $144.65 |
| Indicator | MIRM | SHAK |
|---|---|---|
| Relative Strength Index (RSI) | 71.95 | 62.26 |
| Support Level | $85.98 | $88.24 |
| Resistance Level | $93.70 | $102.96 |
| Average True Range (ATR) | 3.83 | 4.00 |
| MACD | 0.95 | 1.30 |
| Stochastic Oscillator | 87.40 | 71.58 |
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
Shake Shack Inc is a roadside burger stand. It serves a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order, and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water.